Targut Biotechnologies Inc Profile last edited on: 5/14/2024
CAGE: 8GXG4
UEI: C12FZ698PTC1
Business Identifier: Novel solutions to serve unmet clinical needs of gastroenterology patients 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: Richmond
Congr. District: 12
County: Richmond
Public Profile
Targut Biotechnologies Inc is structured atound developing drugs for prevention and treatment of a spectrum of gastroenterological diseases: new tools to improve the lives of gastroenterology patients??: development of small molecules as colorectal cancer preventatives through inhibition of PDE5.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 1 | NIH | $191,738 | |
| Project Title: Colon cancer prevention with non-systemic PDE5 inhibitors | ||||
Key People / Management
Iryna Lebedyeva -- President.
Darren Browning -- Co-Founder and Chief Executive Officer.
Kaylin A Browning -- Research technician
Claudia Fulmer -- Senior Research Scientist
?Bianca Islam -- Co-Founder and CMO??
Darren Browning -- Co-Founder and Chief Executive Officer.
Kaylin A Browning -- Research technician
Claudia Fulmer -- Senior Research Scientist
?Bianca Islam -- Co-Founder and CMO??
Company News
There are no news available.
